GrantRound

Open Federal Grants · National Institutes of Health

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

National Institutes of Health · Opportunity RFA-CA-27-001 · Awards up to $150,000

AgencyNational Institutes of Health
Opportunity NumberRFA-CA-27-001
Award FloorNot stated in the listing
Award Ceiling$150,000
Cost Sharing / MatchingNot required by the listing
Application DeadlineNov 10, 2026 — 27 days left as of Oct 14, 2026
Last Updated on Grants.govJun 3, 2026
Who Can ApplyState governments, County governments, City / township governments, Regional organizations, U.S. territories & freely associated states, Independent school districts, Federally recognized tribal governments, Public housing authorities, Native American tribal organizations, Nonprofits with 501(c)(3) status, Nonprofits without 501(c)(3) status, Private colleges / universities, For-profit organizations, Small businesses, Other applicants

Eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domest

Eligibility text quoted from the official Grants.gov listing.

About This Opportunity

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies offering new capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens for basic, clinical, or epidemiological cancer research. The NOFO solicits R61 applications for early-stage projects proposing proof-of-concept/pilot studies to test the technical feasibility of t …

Description from the official Grants.gov listing — read the complete notice, including any updates, on Grants.gov before applying.

Check Your Fit Get the Free Round-Up

View the official listing on Grants.gov →

More Open Grants From NIH

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)Oct 14, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)Oct 14, 2026
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)Oct 14, 2026
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)Oct 14, 2026
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)Oct 14, 2026

Browse Open Grants

By who can apply:

Nonprofits 856Small Businesses 756State Governments 848Local & Regional Governments 821Tribal Governments & Organizations 851Schools, Colleges & Universities 865Individuals 14Open to All Applicant Types 187

By agency:

NIH 673National Science Foundation 104FDA 54CDC 52HRSA 49Defense Health Agency 47Bureau of Justice Assistance 24Indian Health Service 18NASA Headquarters 16Office of Juvenile Justice Delinquency Prevention 16HUD 15Administration for Community Living 15All agencies & the full hub →

By closing month:

October 2026 102November 2026 145December 2026 54January 2027 62February 2027 23March 2027 18April 2027 22

Every grant listed here comes from Grants.gov, the official U.S. government database. Award amounts and deadlines can change — verify the details on the official listing before you apply. GrantRound is not affiliated with the U.S. government.